Pharming Group N.V. (PHAR) — 20-F Filings
All 20-F filings from Pharming Group N.V.. Browse 3 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (3)
-
Pharming's Revenue Jumps 18.5% on Strong Ruconest, Joenja Sales
— Apr 2, 2026 Risk: medium
Pharming Group N.V. reported a significant increase in revenue to $245.7 million for the fiscal year ended December 31, 2025, up 18.5% from $207.3 million in 20 - 20-F Filing — Apr 3, 2025
-
Pharming Group N.V. Files 20-F Annual Report for Fiscal Year 2023
— Apr 4, 2024 Risk: medium
Pharming Group N.V. (PHAR) filed a Foreign Annual Report (20-F) with the SEC on April 4, 2024. Pharming Group N.V. filed its 20-F annual report for the fiscal y
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX